Here, we studied the implication of IGF1R as a cancer-promoting factor in the TME by analyzing tumor samples from NSCLC patients, and generating LLC models by performing heterotopic transplantation or pulmonary metastasis in the context of IGF1R deficiency. This evidence concerns the gene IGF1R and cancer.